Contact Gregory

Speaking Engagements

  

The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.

09-11 March 2022
  

THE #1 ANTIBODY ENGINEERING CONFERENCE FOR ACCELERATING NEXT GENERATION ANTIBODIES TO COMMERCIAL SUCCESS Brand New Session Themes for 2022: How to Develop an Antibody-based Drug from Discovery to IND? Adaptive Immune Receptor Repertoire Data Processing, Annotation and Interpretation Antibody Engineering, Libraries and Selection Novel Targets for An

04-08 December 2022
  

With numerous next-generation conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads and targeting formats are being thrust centre stage within the bioconjugate world.

21-23 February 2023
  

The Festival of Biologics brings together pharma & biotech, academics and research institutes, together with their partners across the value chain.

20-22 March 2023
  

The world’s largest gathering of protein engineering and biotherapeutics experts is back in Boston! PEGS Boston Summit is the leading biologics event with comprehensive programming covering all aspects of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytics,

15-19 May 2023
  

Toxicity remains the single biggest hurdle in getting ADCs to market, and drug developers are striving to develop safer antibody drug conjugates while keeping efficacy high. Although ADCs have come far, there are still more advancements to be made, highlighted by the blockbuster Enhertu and the recently approved Elahere, both containing Black Box W

25-27 July 2023
  

Next Generation Protein Therapeutics Summit is excited to announce a brand new pre-conference workshop day plus a new main conference day to the 2023 agenda.

18-21 September 2023
  

Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the eagerly anticipated approval of ImmunoGen's ELAHERE, marking the ninth ADC to receive regulatory clear

16-19 October 2023